The 'ROHTO Well-being Report 2022' was selected as one of the "Highest-Performing Integrated Reports" by GPIF's domestic equity investment institutions.
March 29, 2023
ROHTO Pharmaceutical Co., Ltd. (Headquarters: Osaka City, President: Masafumi Sugimoto) announced that its integrated report, "ROHTO Well-being Report 2022," has been selected as one of the "Highly Improved Integrated Reports" by domestic equity investment institutions of the Government Pension Investment Fund (GPIF).
Every year, GPIF requests asset management institutions that manage its domestic equities to select "excellent integrated reports" and "integrated reports with significant improvement," and publishes the results. This year, 95 companies, including ours, were selected for "integrated reports with significant improvement."
Reference: GPIF release
Since 2021, we have been publishing our "Well-being Report," which comprehensively summarizes our financial and non-financial information, to a wide range of stakeholders, including shareholders and investors. In 2022, we identified material issues. Moving forward, we will continue to improve our information disclosure and enhance our corporate value by providing appropriate information, including the "ROHTO Well-being Report," to deepen understanding of our company and gain the trust of our stakeholders.
Reference information regarding our sustainability initiatives